Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...

Cornell researchers have identified a specific brain circuit that could lead to anxiety treatments without cognitive side ...

In addition to preventing the diffusion of toxic species into the CNS, the BBB endothelium serves as a dynamic regulatory system facilitating the transport of molecules from the bloodstream to the ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

A new study on brain activity found that heavy cannabis use is linked to reduced activity in memory-related regions, while ...

In a study published on January 28 in the journal Neuron, the investigators explored how a type of brain receptor called metabotropic glutamate receptor 2 (mGluR2) can be targeted to alleviate ...

Medical and recreational cannabis use is now legal in many parts of the world, but questions remain about its effect on ...

Research indicates that following the onset of an acquired brain injury (ABI), the brain initiates an immediate ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.